Why Sagimet Biosciences Stock Is Soaring Today
The biopharma company confirmed it's still aiming at the United States' acne-treatment market.
ORIGINAL SOURCE →via Motley Fool
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · US
- [CONFLICT] Kral Charles'a ABD yolunda protesto
- [SPORTS] Bilt Rent Day (May 1): Up to a 100% transfer bonus, win a $2,500 styling session in New York City and more
- [CONFLICT] Suspect in Washington dinner shooting set to appear in court
- [CONFLICT] Trump ballroom lawsuit plaintiff rejects DOJ demand to drop case after 'assassination attempt'
- [FINANCE] American Airlines raises $1.14 billion in aircraft bonds
- [TECH] MOL, Partners Earn AiP for Basic Design of an Unmanned Autonomous Rocket Recovery Vessel